Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1

Figure 3

Glucose levels during IPGTT with exenatide in Wfs1^+/+ (a), Wfs1^+/− (b), and Wfs1^−/− mice (c); saline (white dots), exenatide 10 μg/kg (black dots), and glipizide in Wfs1^+/+ (d), Wfs1^+/− (e), and Wfs1^−/− mice (f); saline (white dots), glipizide 0.6 mg/kg (black dots), and glipizide 2 mg/kg (black triangles). in all groups.

(a)

(b)

(c)

(d)

(e)

(f)